ArticleHereditas2026
Ferroptosis-dependent small extracellular vesicles ULK1 enhances mitophagy and suppresses breast cancer migration.
Article in Hereditas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBreast cancer progression is closely influenced by the tumor microenvironment, including macrophage polarization. Small extracellular vesicles (sEVs) derived from tumor cells serve as key mediators of intercellular communication that regulate immune responses. Ferroptosis, characterized by iron-dependent lipid peroxidation, plays a role in tumor progression. However, whether ferroptosis alters the cargo of breast cancer cell-derived sEVs and affects macrophage function remains largely unknown.
resultsIn this study, we identify that sEVs derived from ferroptotic breast cancer cells (Fer-sEVs) are enriched in ULK1 and functionally suppress macrophage M2 polarization. Mechanistically, Fer-sEVs-delivered ULK1 promotes mitophagy in macrophages, thereby inhibiting M2-associated pro-tumoral phenotypes. Knockdown of ULK1 in donor cells abrogated this effect, while autophagy induction by rapamycin reversed consequences of ULK1 depletion. Co-culture experiments revealed that Fer-sEVs-educated macrophages significantly suppressed breast cancer cell migration, whereas ULK1-deficient Fer-sEVs restored migratory capacity. Furthermore, hnRNPA2B1 was identified as the key RNA-binding protein that recognizes EXO-motifs within the ULK1 3’ UTR and mediates its selective packaging into sEVs during ferroptosis. Silencing hnRNPA2B1 reduced ULK1 expression in sEVs.
conclusionTogether, our findings reveal a novel ferroptosis-sEVs-mitophagy axis, in which hnRNPA2B1-mediated sEVs ULK1 delivery enhances mitophagy and reprograms macrophage polarization, ultimately restraining breast cancer migration. This mechanism providing new insights into ferroptosis-based intercellular communication and identifying potential therapeutic targets for breast cancer metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.